Latest Health News
BC-led clinical trial points to safer care for critically ill patients
NEW WESTMINSTER, British Columbia, May 19, 2026 (GLOBE NEWSWIRE) -- A BC-led…
Sanofi: Information concerning the total number of voting rights and shares – April 2026
Information concerning the total number of voting rights and shares, provided pursuant…
Pennant Group to Participate in the 2026 RBC Global Healthcare Conference
May 18, 2026 18:03 ET | Source: Pennant Group, Inc. EAGLE, Idaho,…
Pennant Announces an Acquisition of Senior Living Community in Arizona
May 18, 2026 17:22 ET | Source: Pennant Group, Inc. EAGLE, Idaho,…
ATI Advisory Launches Public Dashboard on C-SNPs and Eligible Populations
New resource offers insight into the characteristics of Medicare beneficiaries enrolling in…
AVITA Medical to Host Investor Webinar Briefing
May 17, 2026 18:00 ET | Source: AVITA Medical VALENCIA, Calif., May…
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026
May 17, 2026 16:00 ET | Source: Design Therapeutics, Inc. CARLSBAD, Calif.,…
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto in metastatic hormone-sensitive prostate cancer
More durable, deeper PSA response in patients treated with Pluvicto plus standard…
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to…
